Lv4
624 积分 2026-04-29 加入
B7-H3 (CD276) as a Candidate Therapeutic Target in Medullary Thyroid Cancer
1个月前
已完结
“Outstanding” ADC Candidates Emerge for SCLC, Other Cancers
1个月前
已关闭
B7-H3 (CD276) as a Candidate Therapeutic Target in Medullary Thyroid Cancer
1个月前
已关闭
Targeting the tumor immune microenvironment in chordoma: From mechanistic insights to therapeutic breakthroughs
1个月前
已完结
Antimetastatic activity of B7-H3-targeted CAR T-cell therapy in triple-negative breast cancer
1个月前
已完结
Blockade for CD276-mediated suppression of tumor-specific cytotoxic T lymphocytes may contribute to achieving durable responses with immune checkpoint inhibitors
1个月前
已完结
Expression of the antibody-drug conjugate targets TROP2, CLDN6, B7-H3, and DLL3 in mesonephric-like adenocarcinoma of the female genital tract
1个月前
已完结
Chemotherapy-Induced Remodeling Versus Clonal Selection in CD276-Driven Basal-Like Chemoresistance in Pancreatic Cancer
1个月前
已关闭
“Outstanding” ADC Candidates Emerge for SCLC, Other Cancers
1个月前
已关闭
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
1个月前
已完结
皖公网安备34019202002308
